Blencowe Resources: Aspiring to become one of the largest graphite producers in the world. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIDP.L Regulatory News (IDP)

  • There is currently no data for IDP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

18 Nov 2020 07:00

RNS Number : 6500F
InnovaDerma PLC
18 November 2020
 

 LEI: 213800WRAP6W8VDL6B38

InnovaDerma PLC

("InnovaDerma" or the "Group")

Appointment of Chief Executive Officer

InnovaDerma (LSE: IDP), a leading developer of beauty, personal care and life science products, is pleased to announce that Blake Hughes has been appointed Chief Executive Officer ("CEO") of the Group with immediate effect. He will be based in the UK.

Blake has spent his career in the beauty and personal care sectors and brings with him extensive marketing and digital analytics experience. Most recently, he held the roles of CEO and Chief Marketing Officer of Philip Kingsley, the award-winning premium hair care range. During his tenure at Philip Kingsley, he defined its brand strategy, transformed its eCommerce platform, created a structured product innovation pipeline and step changed international distribution.

Prior to joining Philip Kingsley, Blake was Managing Director, Europe and Africa, of Murad, the prestigious skin care brand. He successfully transformed the business model of this former UK distribution only joint venture into a profitable regional headquarter that managed the distribution of Murad into Europe, Middle East and Africa.

Blake has also worked in a variety of brand and marketing roles for blue chip companies including Procter & Gamble, Elizabeth Arden and Marks & Spencer. He holds a Masters in Chemistry from Oxford University.

 

Joe Bayer will step down as Interim CEO with immediate effect. He will remain as Executive Chairman to support Blake and ensure a smooth handover of the CEO function. Joe intends to step back to Non-executive Chairman after the transition has been completed.

 

Executive Chairman, Joe Bayer, said:

"After an extensive search process, I am very pleased to announce that Blake Hughes has agreed to assume the role of CEO at InnovaDerma. His impressive leadership record and proven ability to generate topline revenue growth whilst improving margins at both blue chip companies and smaller businesses, together with his sector knowledge of the personal care and beauty business, makes him the ideal candidate to lead InnovaDerma. I look forward to working with him as we continue to expand our digital platform and retail network globally."

 

Blake Hughes said:

"I am really excited to be joining InnovaDerma as its new CEO, it's a business with an impressive stable of strong, digitally focused brands which I have long admired. 

 

"I passionately believe in the company's potential to deliver strong financial growth by continuing to build a sustainable digital competitive advantage, drive brand innovation and create exceptional brand experiences for more consumers around the world. InnovaDerma has significant expansion potential and I am proud to join them at this exciting stage of their development."

 

There is no further information to be disclosed under the requirements of Listing Rule 9.6.13R in relation to Blake Hughes' appointment.

 

 

Further enquiries

 

InnovaDerma

Joe Bayer

 

 

+61 417 870 743

 

finnCap Ltd

Geoff Nash/Kate Bannatyne

Alice Lane - Corporate Broking

 

+44 (0)207 220 0500

www.finncap.com

TB Cardew

Shan Shan Willenbrock/Tom Allison

Olivia Rosser

 

+ 44 (0)20 7930 0777

innovaDerma@tbcardew.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAFFWEFWESSEDF
Date   Source Headline
15th Feb 202112:22 pmBUSForm 8.3 - INNOVADERMA PLC
12th Feb 20216:25 pmRNSForm 8.3 - Innovaderma PLC
12th Feb 20214:43 pmRNSForm 8.3 - [InnovaDerma plc]
12th Feb 20214:40 pmRNSForm 8.3 - [InnovaDerma plc]
12th Feb 20212:35 pmRNSForm 8.3 - Creightons
11th Feb 202111:50 amRNSForm 8.3 - Innovaderma plc
10th Feb 202111:25 amRNSForm 8.3 - Innovaderma plc
10th Feb 202111:03 amRNSForm 8.3 - Innovaderma PLC
9th Feb 20211:18 pmBUSForm 8.3 - INNOVADERMA PLC
5th Feb 20215:14 pmRNSForm 8.3 - Innovaderma Plc
4th Feb 20215:37 pmRNSForm 8 (OPD) CREIGHTONS
4th Feb 20213:31 pmRNSForm 8 (OPD) InnovaDerma PLC
3rd Feb 202112:27 pmBUSForm 8.3 - Innovaderma Plc
2nd Feb 20214:40 pmRNSSecond Price Monitoring Extn
2nd Feb 20214:35 pmRNSPrice Monitoring Extension
2nd Feb 20214:12 pmGNWForm 8.3 - [InnovaDerma plc]
2nd Feb 20212:05 pmRNSSecond Price Monitoring Extn
2nd Feb 20212:00 pmRNSPrice Monitoring Extension
2nd Feb 202111:41 amRNSStatement re Possible Offer
2nd Feb 202111:05 amRNSSecond Price Monitoring Extn
2nd Feb 202111:00 amRNSPrice Monitoring Extension
2nd Feb 20219:05 amRNSSecond Price Monitoring Extn
2nd Feb 20219:00 amRNSPrice Monitoring Extension
28th Jan 202111:22 amRNSHolding(s) in Company
22nd Jan 20214:40 pmRNSSecond Price Monitoring Extn
22nd Jan 20214:36 pmRNSPrice Monitoring Extension
20th Jan 20219:19 amRNSProposed Placing and Proposed Open Offer
18th Jan 202111:59 amRNSHolding(s) in Company
15th Jan 20214:41 pmRNSSecond Price Monitoring Extn
15th Jan 20214:35 pmRNSPrice Monitoring Extension
15th Jan 20217:00 amRNSLoan Agreement
11th Jan 20217:08 amRNSTrading Statement
16th Dec 202012:18 pmRNSResults of the AGM and GM and Directorate Change
2nd Dec 20207:00 amRNSDirectorate Change
24th Nov 20207:02 amRNSDirectorate Change
24th Nov 20207:00 amRNSNotice of General Meeting and adjournment of AGM
18th Nov 20207:00 amRNSDirectorate Change
11th Nov 202012:07 pmRNSAdjournment of AGM
29th Oct 20208:45 amRNSHolding(s) in Company
29th Oct 20208:28 amRNSDirector/PDMR Shareholding
27th Oct 20204:41 pmRNSSecond Price Monitoring Extn
27th Oct 20204:36 pmRNSPrice Monitoring Extension
27th Oct 20202:05 pmRNSSecond Price Monitoring Extn
27th Oct 20202:01 pmRNSPrice Monitoring Extension
23rd Oct 20202:05 pmRNSRequisition notice and Progress of CEO appointment
16th Oct 20204:32 pmRNSNotice of AGM
16th Oct 20209:21 amRNSAppointment of Non-executive Director
15th Oct 20204:40 pmRNSSecond Price Monitoring Extn
15th Oct 20204:35 pmRNSPrice Monitoring Extension
15th Oct 20202:05 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.